Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.

@article{Nassetta2009TreatmentOC,
  title={Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.},
  author={Lauren Nassetta and David W. Kimberlin and Richard J. Whitley},
  journal={The Journal of antimicrobial chemotherapy},
  year={2009},
  volume={63 5},
  pages={862-7}
}
Cytomegalovirus (CMV) infection is the most common cause of congenital infection in the developed world, occurring in approximately 1% of all liveborns. Symptomatic disease occurs in 10% of all congenitally infected infants, resulting in a spectrum of clinical manifestations that include microcephaly, chorioretinitis, hepatosplenomegaly and sensorineural hearing loss, among others. Even those children who are asymptomatic at birth have a risk of hearing loss, with approximately 8% experiencing… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 41 extracted citations

Similar Papers

Loading similar papers…